Trials / Not Yet Recruiting
Not Yet RecruitingNCT07300904
Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial
A Randomized, Controlled, Blinded, Prospective, Multi-center Study Evaluating Tensi+ With Transcutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder Syndrome
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Stimuli Technology · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tensi+ | Transcutaneous Tibial Nerve Stimulation |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2027-01-01
- Completion
- 2027-01-01
- First posted
- 2025-12-24
- Last updated
- 2025-12-24
Locations
3 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07300904. Inclusion in this directory is not an endorsement.